We use essential cookies to make our site work. With your consent, we may also use non-essential cookies to improve user experience and analyze website traffic. By clicking "Accept," you agree to our website's cookie use as described in our Privacy Policy.
This feature is intended for US healthcare providers only. Please complete the form below if you would like a Luminopia representative to contact you regarding more information about Luminopia as a treatment for amblyopia.
Thank you!
We will contact you promptly.
Oops! Something went wrong while submitting the form.
No serious adverse events* reported with Luminopia
Most common adverse event reported (treatment v. control): Headaches (14.3% vs. 1.7%), all graded as mild and transient
Cases of new or worsening heterotropia were balanced between groups (7.1% vs. 8.5%)
Rate of all ocular adverse events similar between groups
Patients should only use Luminopia while wearing their prescribed refractive correction under the headset
Patients should wear Luminopia while seated or lying down
Additional evaluation may be required for patients with a history of light-induced seizures, serious medical conditions, new or worsening eye-turn, or double vision
Patients should stop using Luminopia and contact you for additional evaluation if they experience worsening vision in either eye, headache, nausea, eye strain that doesn't go away after usage, dizziness, or increased night terrors
.png)
